Don’t expect the US shale industry, battered by the pandemic and an oil price war already this year, to move into strong growth levels any time soon, says one oil expert....
Gilead Sciences, Inc. (NASDAQ: GILD) received FDA Emergency Use Authorization for remdesivir in early May as a treatment option for COVID-19 in adults and pediatric patients who are hospitalized with severe disease.The company has since commenced studies for an inhaled formulation of the drug.The Gilead Analyst: BofA Securities analyst Geoff Meacham maintained a Neutral rating on Gilead with an $82 price target. The Gilead Thesis: The news of Gilead kickstarting a Phase 1 study of the inhaled formulation of remdesivir in healthy volunteers this week isn't surprising, Meacham said in a Monday note. (See his track record here.)The company hinted in its first-quarter earnings call that it was investigating improved formulations of its IV drug, including subcutaneous and inhaled versions, the analyst said. Studies of the formulation in COVID-19 patients will be initiated in August, he said. "Still, we suspect the confirmation of a potential inhaled formulation is likely raising concerns...
Virgin Galactic inked a deal with NASA to develop a recruitment and training program for private astronauts looking to visit the International Space Station. Yahoo Finance’s Emily McCormick and Akiko Fujita discuss. ...
Electrified truck powertrain developer Hyliion Inc. plans to merge with Tortoise Acquisition Corp., an acquisition company that focuses on the energy sector and decarbonizing commercial transportation. ...
Hyliion Inc. has announced it intends to merge with Tortoise Acquisition Corp., an acquisition company that focuses on the energy sector and decarbonizing commercial transportation. ...
By now, I'm assuming you've heard about President Trump's plan to jump-start the U.S. economy by spending $1 trillion on an "infrastructure plan." You really should have heard of it by now... because he's been promising it for about four straight years. But could 2020, with its arrival of a coronavirus and a recession that's cost more than 40 million Americans their jobs, be the year that it finally happens?Maybe.In Rosenblatt's latest report on the subject, analyst Ryan Koontz admits that there have been "years of infrastructure talk from all sides and surprisingly little to show for it." But he also argues that passing an infrastructure bill, as an economic stimulus measure to get people back to work and help restart the economy, "makes sense" and is "broadly favored in public polling," suggesting that 2020 could be the year there's enough public support to get such a plan through Congress.Moreover, the...
